Kakao Healthcare, the digital healthcare business of South Korean internet company Kakao Corporation, has partnered with Novo Nordisk to further develop its diabetes management service powered by mobile and AI technologies.
The two organisations recently signed a memorandum of understanding to launch a smart healthcare service to support patients with diabetes. According to a press release, Kakao...
The South Korean Ministry of Food and Drug Safety has approved the first locally-developed continuous glucose monitoring device.
The CareSens Air, developed by blood glucose device maker i-SENS, is touted to be the smallest and lightest CGM device available in South Korea. It can also be used for 15 days straight and features a calibration mechanism to make readings more reliable.
Following this...
The digital healthcare business of South Korean internet company Kakao Corporation has entered into a collaboration agreement with Dexcom to set up a global digital diabetes management service.
According to a press statement, the deal combines Kakao Healthcare's capabilities in AI and software technology with Dexcom's continuous glucose monitoring (CGM) devices, Dexcom G6 and G7, which the...
Taiwan-based digital health startup Health2Sync and French multinational pharmaceutical firm Sanofi have signed another partnership to bring digital solutions for insulin management to Japan.
WHAT IT'S ABOUT
According to a press statement, both companies will jointly develop digitised features on insulin in Japan, including connected caps for insulin and titration alerts.
Health2Sync has a mobile...
A team-based digital approach to care could be key for treating patients with diabetic kidney disease (DKD), according to results of a new study in JAMA.
Researchers found that patients enrolled in the Joint Asia Diabetes Evaluation (JADE) web portal who received a team-based empowered-care program met more of their treatment targets than the participants enrolled in standard of care or a...
Digital diabetes and chronic condition management company Glooko announced Monday it had acquired Berlin-based xbird, maker of AI-based diabetes care tools.
xbird monitors patients' activity with sensors and wearables, using artificial intelligence and machine learning to find potential problems and alert users to take action, like a nudge to check blood glucose levels.
"xbird and Glooko are a...
Health2Sync, a digital health startup based in Taiwan, and French multinational pharmaceutical firm Sanofi have extended their collaboration to soon come up with and market a new insulin management solution.
WHY IT MATTERS
The companies noted the "suboptimal" use of insulin in Taiwan and Asia. A recent study published in the Journal of Diabetes Investigation shared that approximately half of...
.jpeg?itok=HF3iI7dj "Person answering their front door and getting a delivery from another person")
